HCPCS Codes Similar to J9029

HCPCS Codes Similar to “J9029” Code.
Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose

J9030 Bcg live intravesical instillation, 1 mg Code added date: 20190701 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	J9031 Bcg (intravesical) per instillation Code added date: 19910101 Code effective date: 20190701 TXT \| PDF \| XML \| JSON
A9543 Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries Code added date: 20060101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	A9545 Iodine i-131 tositumomab, therapeutic, per treatment dose Code added date: 20060101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
A9604 Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries Code added date: 20100101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	C1717 Brachytherapy source, non-stranded, high dose rate iridium-192, per source Code added date: 20010401 Code effective date: 20010401 TXT \| PDF \| XML \| JSON
C1719 Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source Code added date: 20010401 Code effective date: 20010401 TXT \| PDF \| XML \| JSON	C9073 Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20210101 Code effective date: 20210401 TXT \| PDF \| XML \| JSON
C9076 Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20210701 Code effective date: 20211001 TXT \| PDF \| XML \| JSON	C9081 Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20211001 Code effective date: 20220101 TXT \| PDF \| XML \| JSON
C9098 Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20220701 Code effective date: 20221001 TXT \| PDF \| XML \| JSON	C9172 Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose Code added date: 20241001 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
C9301 Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Code added date: 20250401 Code effective date: 20250701 TXT \| PDF \| XML \| JSON	E0787 External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing Code added date: 20200101 Code effective date: 20200915 TXT \| PDF \| XML \| JSON